Picture of Strides Pharma Science logo

STAR — Strides Pharma Science News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Strides Pharma Science Gets USFDA Approval For Theophylline Extended-Release Tablet

Sept 6 (Reuters) - Strides Pharma Science Ltd  SRID.NS :
    * STRIDES PHARMA SCIENCE LTD - GETS  USFDA APPROVAL FOR
THEOPHYLLINE EXTENDED-RELEASE TABLET

Source text for Eikon:  ID:nBSE3w42Yc 
Further company coverage:  SRID.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Strides Pharma Science

See all news